Scientists create custom Cancer-Killing antibodies for each patient
NCT ID NCT06674538
Summary
This early-stage trial is testing whether custom-made antibodies can safely help the body attack advanced cancer. Doctors will create unique antibodies for each patient using samples from their own tumor. The goal is to see if these personalized antibodies can target cancer cells while sparing healthy tissue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Penn State Cancer Institute
Hershey, Pennsylvania, 17033, United States
Conditions
Explore the condition pages connected to this study.